FDA Inspection 759369 — Aesica Pharmaceutical GmbH

Aesica Pharmaceutical GmbH — FEI 3002943189

The FDA completed an inspection of Aesica Pharmaceutical GmbH on Nov 11, 2011 in Monheim am Rhein. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 11, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Monheim am Rhein (Germany)

Citations

IDCFRDescription
435221 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.